|

COPD Clinical Trials in Michigan

24 recruiting studies across 13 cities

All Trials in Michigan

Phase
Trial Phase Location
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Phase 3Allen Park
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePhase 3Allen Park
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 InflammationPhase 3Allen Park
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3Ann Arbor
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Phase 3Ann Arbor
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3N/AAnn Arbor
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDPhase 2Ann Arbor
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePhase 3Ann Arbor
Multi-Center Clean Air Randomized Controlled Trial in COPDPhase 3Ann Arbor
SPIROMICS Study of Early COPD Progression (SOURCE)—Ann Arbor
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2—Ann Arbor
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency DepartmentN/AAnn Arbor
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 InflammationPhase 3Clarkston
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseasePhase 2/3Dearborn
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDPhase 2Dearborn
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe EmphysemaN/ADetroit
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDN/ADetroit
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)N/ADetroit
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPDN/ADetroit
Supporting Evidence-based Responses to Emotional Needs in EmphysemaN/ADetroit
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeN/ADetroit
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePhase 2Farmington Hills
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)Phase 3Farmington Hills
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)Phase 2Southfield

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.